|1.||Granados, J: 2 articles (01/2012 - 01/2012)|
|2.||García-Romero, M T: 2 articles (01/2012 - 01/2012)|
|3.||Vega-Memije, M E: 2 articles (01/2012 - 01/2012)|
|4.||Arenas, R: 2 articles (01/2012 - 01/2012)|
|5.||Capello, Michela: 1 article (09/2015)|
|6.||Bogantes Hernandez, Pablo Josè: 1 article (09/2015)|
|7.||Bertinetto, Francesca Eleonora: 1 article (09/2015)|
|8.||Magistroni, Paola: 1 article (09/2015)|
|9.||Rendine, Sabina: 1 article (09/2015)|
|10.||Dametto, Ennia: 1 article (09/2015)|
|1.||Autoimmune Thyroiditis (Lymphomatous Thyroiditis)
04/01/1994 - "Of the HLA-class II antigens, the frequency of HLA-DR8 was significantly greater among the 23 Korean patients with TBII-positive atrophic autoimmune thyroiditis compared to control subjects (Pc = 0.003). "
04/01/1994 - "When the HLA-DR8 positive patients with TBII-positive atrophic autoimmune thyroiditis and controls were analyzed separately, the DR8 positive patients with TBII-positive atrophic autoimmune thyroiditis had more homozygotes for the TNF beta * 1 allele(6/12, 50.0%) and no homozygotes for the TNF beta * 2 allele, as compared to the DR8 negative patients with TBII-positive atrophic autoimmune thyroiditis and DR8 positive controls(P < 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)"
04/01/1994 - "The tumor necrosis factor beta * 1 allele is linked significantly to HLA-DR8 in Koreans with atrophic autoimmune thyroiditis who are positive for thyrotropin receptor blocking antibody."
09/01/1993 - "The antigen frequency of HLA-DR8 was significantly increased in 23 atrophic autoimmune thyroiditis patients that were positive for TSH binding inhibitor immunoglobulin (TBII) compared to 136 controls [52% vs. 16%; chi 2 = 13.1; Pc (corrected P value) = 0.003]. "
09/01/1993 - "A strong association between thyrotropin receptor-blocking antibody-positive atrophic autoimmune thyroiditis and HLA-DR8 and HLA-DQB1*0302 in Koreans."
03/01/1987 - "HLA-A2, Bw61, and DRw9 were associated with ocular myasthenia gravis (corrected p [CP] less than 0.05 relative risk [RR] = 2.88; CP less than 0.02, RR = 3.60; and CP less than 0.001, RR = 4.63, respectively) and HLA-DRw8 was associated with generalized myasthenia gravis (CP less than 0.001, RR = 5.40). "
05/01/1988 - "The relationship between the histocompatibility leukocyte antigen (HLA) phenotypes and the clinical course of myasthenia gravis (MG) was studied in 53 Japanese patients with MG. The frequency of HLA-DRw9 antigen was high in the MG patients who did not need immunosuppressive therapy but only anticholinesterase agents (RR = 4.52; CP less than 0.02), who achieved remission of the disease (RR = 2.98; CP less than 0.05) or who showed a decrease in AChR antibody (Ab) titer (RR = 6.32; CP less than 0.0002), whereas the frequency of HLA-DRw8 antigen was increased in MG patients who underwent immunosuppressive therapy (RR = 4.03; CP less than 0.01), who did not have remission (RR = 4.75; CP less than 0.1) or who showed an increase in AChR Ab titer (RR = 6.48; CP less than 0.01). "
|3.||Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
04/01/1995 - "Furthermore, high responders to B1-p28 were observed frequently in primary biliary cirrhosis patients with HLA DR8 (p < 0.02), which was susceptible to the development of primary biliary cirrhosis. "
11/01/1994 - "C4B2 genotyping was performed on 64 patients with primary biliary cirrhosis and 61 controls matched for ethnic background and frequency of HLA-DR8. "
06/01/1993 - "We found an increased frequency of HLA-DR8 (18.5% vs 9.2%, p < 0.005, relative risk of 2.0 [1.3-3.1]) in the primary biliary cirrhosis group. "
12/01/1992 - "Susceptibility to primary biliary cirrhosis is associated with the HLA-DR8-DQB1*0402 haplotype."
09/01/1992 - "HLA DRw8 and primary biliary cirrhosis."
04/01/1996 - "We found HLA-DR8 was a candidate for susceptibility to anterior uveitis in AS."
04/01/1996 - "Twelve cases (63.2%) with anterior uveitis had expressed HLA-DR8 (DRB1 0803). "
04/01/1995 - "HLA-DR8 and acute anterior uveitis in ankylosing spondylitis."
08/01/1989 - "Chronic anterior uveitis (6 of 35), antinuclear antibodies (22 of 35), anticollagen antibodies (10 of 35), HLA-DR4 (2 of 28), and HLA-DR8 (5 of 28) occurred with frequencies similar to those seen in patients with juvenile rheumatoid arthritis. "
|2.||Histocompatibility Antigens Class II
|4.||Cholinesterase Inhibitors (Anticholinesterases)
|5.||HLA-DR7 Antigen (HLA DR7 Antigen)
|6.||HLA-DR5 Antigen (HLA DR5 Antigen)
|7.||HLA-DR4 Antigen (HLA DR4 Antigen)
|8.||Thyrotropin Receptors (Thyrotropin Receptor)